Ellagic Acid and the Metabolite Urolithin A Suppress HSV-1 Infection and Brain Inflammation by Targeting Casein Kinase CK2
Journal of Agricultural and Food Chemistry · 2025
DOI: 10.1021/acs.jafc.5c04281 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Agricultural and Food Chemistry, 2025. Verfasst von Weikang Sun und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Pharmaceutical Biotechnology, Medical School, Nanjing University, Nanjing 210093, China. Hauptthemen laut MEDLINE: Ellagic Acid, Casein Kinase II, Herpesvirus 1, Human, Antiviral Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key R&D Program of China.
Abstract (Originalsprache)
Plant-based phenolic components and their metabolites, such as ellagic acid (EA) and urolithin A (UA), possess a variety of biological activities. Here, we investigated the antiviral effect of EA and UA against HSV-1 infection, a virus that causes peripheral infection as well as brain inflammation. Both compounds demonstrated potent antiviral activity. Network pharmacology and molecular docking analyses identified protein kinase CK2 as a common target for their action. We showed that both EA and UA were direct CK2 inhibitors using an enzymatic assay, an observation substantiated in cell culture studies. The effect of EA and UA on HSV-1 infection through CK2 was confirmed in CK2 (CSNK2B) knockout cells. Finally, we demonstrated an antiviral effect using a murine model of herpetic stromal keratitis. EA or UA treatment reduced HSV-1 shedding and prevented viral neuroinvasion. CK2 is a critical enzyme involved in cell proliferation and the proinflammatory response. In addition to identifying CK2 as a putative target of EA and UA antiviral activities, this study also demonstrates that EA and its metabolite UA have the potential to reduce infection-associated neurodegenerative inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Pharmaceutical Biotechnology, Medical School, Nanjing University, Nanjing 210093, China.
- Jiangsu Key Laboratory of Molecular Medicine, Medical School, Nanjing University, Nanjing 210093, China.
- Jiangsu Provincial Medical Innovation Center, The Affiliated Hospital of Integrated Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing 210028, China.
- Division of Pediatrics, Chuantou Xichang Hospital Xichang 615000 China.
- College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China.
ORCID-Profile: Peng Cao, Erguang Li
Förderung
- National Natural Science Foundation of China
- National Key R&D Program of China
Zitieren
APA
Sun, W., Luo, R., Qu, Q., Yang, J., Yang, G., Song, L., Cao, P., & Li, E. (2025). Ellagic Acid and the Metabolite Urolithin A Suppress HSV-1 Infection and Brain Inflammation by Targeting Casein Kinase CK2. Journal of Agricultural and Food Chemistry. https://doi.org/10.1021/acs.jafc.5c04281
Vancouver
Sun W, Luo R, Qu Q, Yang J, Yang G, Song L, et al. Ellagic Acid and the Metabolite Urolithin A Suppress HSV-1 Infection and Brain Inflammation by Targeting Casein Kinase CK2. Journal of Agricultural and Food Chemistry. 2025. doi:10.1021/acs.jafc.5c04281
BibTeX
@article{Sun2025,
author = {Sun, Weikang and Luo, Renjie and Qu, Qingwei and Yang, Jie and Yang, Guang and Song, Lihua and Cao, Peng and Li, Erguang},
title = {Ellagic Acid and the Metabolite Urolithin A Suppress HSV-1 Infection and Brain Inflammation by Targeting Casein Kinase CK2},
journal = {Journal of Agricultural and Food Chemistry},
year = {2025},
doi = {10.1021/acs.jafc.5c04281}
}
EUVIMED